Oncolytics Biotech Inc. - Product Pipeline Review - 2012 New Report


Naperville, IL -- (SBWire) -- 09/27/2012 --Oncolytics Biotech Inc. - Product Pipeline Review - 2012 provides data on the Oncolytics Biotech Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.


- Oncolytics Biotech Inc. - Brief Oncolytics Biotech Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Oncolytics Biotech Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Oncolytics Biotech Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Oncolytics Biotech Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Oncolytics Biotech Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Oncolytics Biotech Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Oncolytics Biotech Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Oncolytics Biotech Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Oncolytics Biotech Inc. and identify potential opportunities in those areas.


Current R&D Portfolio of Oncolytics Biotech Inc.; Oncolytics Biotech Inc. - Key Therapeutics; Oncolytics Biotech Inc. - Pipeline Overview and Promising Molecules; Oncolytics Biotech Inc. - News; Oncolytics Biotech Inc. - Latest Updates; Oncolytics Biotech Inc. - Pipeline; Oncolytics Biotech Inc. - Discontinued/Dormant Projects

To view table of contents for this market report please visit:

Media Relations Contact

Web Master

View this press release online at: http://rwire.com/167519